Skip to main content
Clinical Trials/JPRN-jRCTs052180228
JPRN-jRCTs052180228
Completed
Phase 3

Effects of gait exercise assist robot on the chronic stroke patients - EGEARCSP

Domen Kazuhisa0 sites20 target enrollmentMarch 30, 2019

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Domen Kazuhisa
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study was to investigate whether gait training using GEAR is more effective for increasing gait ability in chronic stroke subjects. The subjects were 20 patients with chronic stroke, who were randomly assigned to the GEAR group and the treadmill group. All subjects participated in a training program comprising 20 sessions a 1 h/day, 5 days/week for 4 weeks.This study suggests that gait training using GEAR was effective for improving gait ability among subjects with chronic stroke.

Registry
who.int
Start Date
March 30, 2019
End Date
March 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Domen Kazuhisa

Eligibility Criteria

Inclusion Criteria

  • 1\. \>6 months duration after stroke
  • 2\. Hemiparesis of unilateral, supratentorial, ischemic, or
  • hemorrhage stroke
  • 3\. Independent in ground ambulation with or without the
  • use of a unilateral assistive device (standard cane,
  • four\-pronged cane) and with or without the use of a an
  • ankle foot orthoses
  • 4\. Independent in treadmill gait training
  • 5\. approval for study participation

Exclusion Criteria

  • 1\. Cannot obey instructions of a healer (scores \< 23 on the Mini Mental Status examination, etc)
  • 2\. Significant cardiorespiratory/metabolic disease, or orthopedic injury or other neurological
  • 3\. Excessive spasticity (defined as Ashworth scale of
  • greater than 3 at any lower limb joint)
  • 4\. Size limitations for the harness/counterweight system or robotic orthosis
  • 5\. No botulinum toxin therapy in the lower limbs \< 4 months
  • prior to enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials